A Retrospective Study Showing the Extent of Compliance With Perioperative Guidelines in Patients With Coronary Stents With Regard to Double Antiplatelet Therapy

    loading  Checking for direct PDF access through Ovid


(Abstracted from J Clin Anesth, 33:179–184, 2016)

In patients with obstructive coronary artery disease, therapy using percutaneous coronary intervention with bare-metal stent and drug-eluting stent placement has been found to be very effective despite challenges to the perioperative management of these patients. Dual antiplatelet therapy (DAPT), specifically a P2Y12 receptor inhibitor (clopidogrel, ticagrelor, prasugrel, orticlopidine) in addition to aspirin, is used to prevent coronary artery in-stent thrombosis, caused by complete and premature discontinuation of DAPT.

Related Topics

    loading  Loading Related Articles